Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.
- DOI
- 10.1186/s13148-019-0651-z
- Published
- 2019 Mar 27
- Container
- Clinical epigenetics
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1186/s13148-019-0651-z,
title = {Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.},
author = {Kamdar S and Isserlin R and Van der Kwast T and Zlotta AR and Bader GD and Fleshner NE and Bapat B},
year = {2019},
journal = {Clinical epigenetics},
doi = {10.1186/s13148-019-0651-z},
url = {https://doi.org/10.1186/s13148-019-0651-z}
}RIS
TY - JOUR TI - Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression. AU - Kamdar S AU - Isserlin R AU - Van der Kwast T AU - Zlotta AR AU - Bader GD AU - Fleshner NE AU - Bapat B PY - 2019 JO - Clinical epigenetics DO - 10.1186/s13148-019-0651-z UR - https://doi.org/10.1186/s13148-019-0651-z ER -
APA
S, K., R, I., T, V. D. K., AR, Z., GD, B., NE, F., & B, B. (2019). Exploring targets of TET2-mediated methylation reprogramming as potential discriminators of prostate cancer progression.. Clinical epigenetics. https://doi.org/10.1186/s13148-019-0651-z
Source records
- pubmed · retrieved 2026-09-26T21:24:37.313Z